Baker Daniel G. Insider Trades

Insider Trading History

Track insider trading activity for Baker Daniel G.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cue Biopharma
Cue Biopharma CUE
CHIEF DEVELOPMENT OFFICER
Holding Value $2.69M 100,000 shares
Last Trade
Apr 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29k 100,000 shares
$0.29
$26.91
Cue Biopharma
Cue Biopharma CUE
CHIEF DEVELOPMENT OFFICER
Holding Value $1.35M 50,000 shares
Last Trade
Sep 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36k 50,000 shares
$0.72
$26.91
Shattuck Labs
Shattuck Labs STTK
Director
Holding Value $315k 66,300 shares
Last Trade
Aug 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.6k 66,300 shares
$0.99
$4.75
Artiva Biotherapeutics
Artiva Biotherapeutics ARTV
Director
Holding Value $95.8k 13,750 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 13,750 shares
$1.61
$6.97
Cue Biopharma
Cue Biopharma CUE
CHIEF DEVELOPMENT OFFICER
Holding Value $2.69M 100,000 shares
Last Trade
Mar 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99k 100,000 shares
$0.99
$26.91
Artiva Biotherapeutics
Artiva Biotherapeutics ARTV
Director
Holding Value $192k 27,500 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$153k 27,500 shares
$5.56
$6.97
Cue Biopharma
Cue Biopharma CUE
CHIEF DEVELOPMENT OFFICER
Holding Value $5.38M 200,000 shares
Last Trade
Nov 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 200,000 shares
$1.06
$26.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up